Millipore Sigma Vibrant Logo

444289 Marimastat - CAS 154039-60-8 - Calbiochem

Marimastat, CAS 154039-60-8, is a broad-spectrum MMP inhibitor (IC50 = 5, 6, 200, 20, 2, 1.8 & 3.8 nM for MMP-1, -2, -3, -7, -8, -14 and TACE, respectively).

Marimastat - CAS 154039-60-8 - Calbiochem: SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: (2S,3R)-N⁴-((1S)-2,2-Dimethyl-1-((methylamino)carbonyl)propyl)-N¹,2-hydroxy-3-(2-methylpropyl)butanediamide, BB-2516

View Products on Sigmaaldrich.com
444289
Preis & Verfügbarkeit

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
154039-60-8C₁₅H₂₉N₃O₅

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
444289-5MG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Kst.-Ampulle 5 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewAn orally active peptidyl hydroxamate-based broad-spectrum MMP inhibitor (IC50 in nM = 5, 6, 200, 20, 2, 1.8 and 3.8 for MMP-1, -2, -3, -7, -8, -14 and TACE, respectively) that targets both the substrate binding site and the active-site Zn2+. Marimastate is widely used in studying the involvement of MMPs in various cellular and pathological processes both in vitro and in vivo.
      Catalogue Number444289
      Brand Family Calbiochem®
      Synonyms(2S,3R)-N⁴-((1S)-2,2-Dimethyl-1-((methylamino)carbonyl)propyl)-N¹,2-hydroxy-3-(2-methylpropyl)butanediamide, BB-2516
      References
      ReferencesHansen, H.P., et al. 2002. Int. J. Cancer 98, 210.
      Tsuji, F., et al. 2002. Cytokine 17, 294.
      Barlaam, B., et al. 1999. J. Med. Chem. 42, 4890.
      Whittaker, M., et al. 1999. Chem. Rev. 99, 2735.
      Rasmussen, H.S., and McCann, P.P. 1997. Pharmacol. Ther. 75, 69.
      Product Information
      CAS number154039-60-8
      FormWhite solid
      Hill FormulaC₁₅H₂₉N₃O₅
      Chemical formulaC₁₅H₂₉N₃O₅
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      ApplicationMarimastat, CAS 154039-60-8, is a broad-spectrum MMP inhibitor (IC50 = 5, 6, 200, 20, 2, 1.8 & 3.8 nM for MMP-1, -2, -3, -7, -8, -14 and TACE, respectively).
      Biological Information
      Purity≥98% by NMR
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      S PhraseS: 22-24/25-36/37/39

      Do not breathe dust.
      Avoid contact with skin and eyes.
      Wear suitable protective clothing, gloves and eye/face protection.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      444289-5MG 04055977186062

      Documentation

      Marimastat - CAS 154039-60-8 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Marimastat - CAS 154039-60-8 - Calbiochem Analysenzertifikate

      TitelChargennummer
      444289

      Literatur

      Übersicht
      Hansen, H.P., et al. 2002. Int. J. Cancer 98, 210.
      Tsuji, F., et al. 2002. Cytokine 17, 294.
      Barlaam, B., et al. 1999. J. Med. Chem. 42, 4890.
      Whittaker, M., et al. 1999. Chem. Rev. 99, 2735.
      Rasmussen, H.S., and McCann, P.P. 1997. Pharmacol. Ther. 75, 69.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision25-August-2009 RFH
      Synonyms(2S,3R)-N⁴-((1S)-2,2-Dimethyl-1-((methylamino)carbonyl)propyl)-N¹,2-hydroxy-3-(2-methylpropyl)butanediamide, BB-2516
      DescriptionAn orally active peptidyl hydroxamate-based broad-spectrum MMP inhibitor (IC50 in nM = 5, 6, 200, 20, 2, 1.8 and 3.8 for MMP-1, -2, -3, -7, -8, -14 and TACE, respectively) that targets both the substrate binding site and the active-site Zn2+. Marimastate is widely used in studying the involvement of MMPs in various cellular and pathological processes both in vitro and in vivo.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number154039-60-8
      Chemical formulaC₁₅H₂₉N₃O₅
      Structure formulaStructure formula
      Purity≥98% by NMR
      SolubilityDMSO (15 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesHansen, H.P., et al. 2002. Int. J. Cancer 98, 210.
      Tsuji, F., et al. 2002. Cytokine 17, 294.
      Barlaam, B., et al. 1999. J. Med. Chem. 42, 4890.
      Whittaker, M., et al. 1999. Chem. Rev. 99, 2735.
      Rasmussen, H.S., and McCann, P.P. 1997. Pharmacol. Ther. 75, 69.